-
公开(公告)号：US20230210394A1
公开(公告)日：2023-07-06
申请号：US18159241
申请日：2023-01-25
申请人： Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. , Boehringer Ingelheim Vetmedica GmbH
IPC分类号： A61B5/0255 , A61B5/00 , A61B7/04
CPC分类号： A61B5/0255 , A61B5/7264 , A61B7/04 , A61B2503/40
摘要： A method for analyzing an acoustic signal having a time period and having a plurality of repeated audio patterns, has the following steps: receiving an audio signal having the acoustic signal; determining the audio patterns repeated within the acoustic signal; determining a window length for a plurality of windows, wherein the window length divides the time period of the acoustic signal into the plurality of windows; and windowing the acoustic signal to obtain the plurality of windows.
-
公开(公告)号：US20190008863A1
公开(公告)日：2019-01-10
申请号：US16131499
申请日：2018-09-14
IPC分类号： A61K31/501 , A61P9/04
摘要： Pimobendan is used for reducing the heart size and/or delaying the onset of clinical symptoms in a patient suffering from asymptomatic (occult, preclinical) heart failure, preferably congestive heart failure, due to mitral valve disease (MVD), and/or delaying the onset of heart failure, preferably congestive heart failure, in a patient suffering from asymptomatic (occult, preclinical) heart failure, preferably congestive heart failure, due to mitral valve disease (MVD), wherein the patient is preferably a mammal, more preferably a human, a dog, a cat or a horse, and most preferably a dog.
-
3.发明公开公开(公告)号：US20240269105A1
公开(公告)日：2024-08-15
申请号：US18578205
申请日：2022-07-26
IPC分类号： A61K31/351 , A61K45/06 , A61P9/12
CPC分类号： A61K31/351 , A61K45/06 , A61P9/12
摘要： The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof for the prophylaxis and/or treatment of hypertension in a non-human mammal, preferably a carnivore, in particular a cat or a dog.
-
-
搜索结果
3 条记录 (耗时 0.021 秒)
